CoroWare, Inc.
26.10.2021 14:32:23 CEST | ACCESS Newswire | Press release
Founding members bring decades of management and technology leadership
OXFORD, ENGLAND and WOODINVILLE, WA / ACCESSWIRE / October 26, 2021 / CoroWare (OTC PINK:COWI) today announced that CarbonMeta Research Ltd, a wholly owned subsidiary of CoroWare that is based in Oxford, England, appointed Tiancun Xiao and Mohammed Khalil to the subsidiary's Board of Directors.
Dr. Xiao is a Senior Research Fellow at University of Oxford, has contributed to the development of novel catalysts and corresponding process for microwave assisted catalysis, which can selectively break C-H or C-C bond in hydrocarbons, including natural gas, liquid hydrocarbon, wax and polymers such as polyethylene, polypropylene, polystyrene and tyres. Dr Xiao has rich experiences in commercializing patent and transferring to industrial operation. He co-founded Oxford Catalyst Ltd in 2004, now rebranded as Velocys. He is also a co-founder of OxCCU Tech Ltd, a spinout company from Oxford University focusing on thermally catalysis in converting CO2 into aviation fuel or valuable chemicals.
Mr. Khalil is the co-founder of EcoMENA, an award-winning environmental platform that fosters sustainability, waste management and renewable energy in the Middle East and North Africa region. Mr. Khalil is also the Director and Co-Founder of Fusor Tech, an additive manufacturing company based in the England that is focused on producing advanced metal parts and additive manufacturing technologies for the space, oil & gas, marine and medical industries.
"I could not be more excited to welcome and announce the appointments of Mr. Khalil and Dr. Xiao to the Board of Directors of CarbonMeta Research," said Lloyd Spencer, Chairman and CEO of CoroWare., "They bring decades of leadership in key areas such as strategy implementation, technology development, and operational management, all of which will be vital to the success of CarbonMeta Research and CoroWare."
Mr. Khalil will serve as Managing Director, Dr. Xiao will serve as Chief Technology Officer, and Mr. Spencer will serve as Chairman of the Board of Directors of CarbonMeta Research Ltd.
About CarbonMeta Research Ltd.
CarbonMeta Research Ltd. is a wholly owned subsidiary of CoroWare that is based in the United Kingdom, and whose focus will be on the development of technologies and solutions for processing organic wastes and generating economically sustainable hydrogen and high-value carbon products.
For more information about the company, please visit www.carbonmetaresearch.co.uk.
About CoroWare Inc.
CoroWare Inc. (OTC PINK:COWI), headquartered in Woodinville, Washington, is in the early stage of transitioning into a resource reclamation company that will process organic wastes and generate economically sustainable hydrogen and high-value carbon products.
For more information about the company, please visit www.CoroWare.com.
Forward-Looking Statement
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The ability of the Company to complete and file its Fiscal Year 2016 annual report on Form 10K relies on third parties to complete their activities. Investors are cautioned that such forward-looking statements involve risks and uncertainties, which include among others, the inherent uncertainties associated with smaller reporting companies, including without limitation, other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.
CONTACT INFORMATION
Mark Duiker
CoroWare Investor Relations
(844) 641-2676, option 3
Investor@CoroWare.com
SOURCE: CoroWare, Inc.
View source version on accesswire.com:
https://www.accesswire.com/669384/CoroWare-Subsidiary-CarbonMeta-Research-Ltd-Appoints-Board-of-Director-Members
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom